Kural Merve, Rosenkranz Stephan, Baldus Stephan, Bunck Alexander Christian, Tichelbäcker Tobias
Department of Cardiology, Pulmonology and Intensive Care Medicine, Heart Center, University of Cologne, Kerpener Str. 62, Cologne 50937, Germany.
Department of Radiology, University of Cologne, Kerpener Str. 62, Cologne 50937, Germany.
Eur Heart J Case Rep. 2025 Aug 25;9(8):ytaf342. doi: 10.1093/ehjcr/ytaf342. eCollection 2025 Aug.
First-line therapy for high-risk pulmonary embolism (PE) is systemic thrombolysis. Catheter-directed thrombectomy (CDT) poses as a secondary option, primarily in patients with contraindications for systemic thrombolysis. However, in patients with haemodynamic instability or cardiac arrest, CDT can worsen the haemodynamic situation making use of large thrombectomy catheters. The implementation of extracorporeal life support such as veno-arterial extracorporeal membrane oxygenation (VA-ECMO) can play a decisive role in making CDT possible. Herein, we present a case of CDT on a high-risk PE patient under VA-ECMO.
A 73-year-old White male was hospitalized in order to perform abdominal surgery. Afterwards, multiple complications led to recurring operations and a prolonged immobilization time. In the aftermath, the patient suffered an in-hospital cardiac arrest and was put on VA-ECMO. A computed tomography pulmonary angiography presented bilateral central PE. Due to contraindications for systemic thrombolysis, successful CDT using a FlowTriever catheter was performed, leading to a reduction of mean pulmonary arterial pressure. ECMO therapy could be terminated in the following days. The patient was eventually discharged without any signs of right heart strain in transthoracic echocardiogram, neurological sequelae or dyspnoea.
According to current ESC-guidelines, first-line therapy for high-risk PE is systemic thrombolysis, and CDT is a secondary option. In our case, CDT under VA-ECMO was feasible and led to a rapid improvement in haemodynamics, resulting in a long-term recovery. Thus, the definite significance of CDT has yet to be identified, especially concerning PE with refractory cardiac arrest and contraindications for systemic thrombolysis.
高危肺栓塞(PE)的一线治疗是全身溶栓。导管定向血栓切除术(CDT)作为二线选择,主要用于有全身溶栓禁忌证的患者。然而,对于血流动力学不稳定或心脏骤停的患者,使用大型血栓切除导管进行CDT可能会使血流动力学情况恶化。实施体外生命支持,如静脉-动脉体外膜肺氧合(VA-ECMO),在使CDT成为可能方面可发挥决定性作用。在此,我们报告一例在VA-ECMO支持下对高危PE患者进行CDT的病例。
一名73岁白人男性因行腹部手术入院。术后,多种并发症导致反复手术和长时间制动。随后,患者在医院发生心脏骤停,并接受了VA-ECMO治疗。计算机断层扫描肺动脉造影显示双侧中心型PE。由于存在全身溶栓禁忌证,使用FlowTriever导管成功进行了CDT,导致平均肺动脉压降低。随后几天ECMO治疗得以终止。患者最终出院,经胸超声心动图检查未发现右心劳损迹象、神经后遗症或呼吸困难。
根据当前欧洲心脏病学会(ESC)指南,高危PE的一线治疗是全身溶栓,CDT是二线选择。在我们的病例中,VA-ECMO支持下的CDT是可行的,并导致血流动力学迅速改善,实现了长期康复。因此,CDT的确切意义尚待确定,尤其是对于伴有难治性心脏骤停和全身溶栓禁忌证的PE患者。